z-logo
open-access-imgOpen Access
Antibiotics and proton pump inhibitors suppress the efficacy of immunotherapy against non‐small cell lung cancer
Author(s) -
Diao Xiayao
Publication year - 2020
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.13470
Subject(s) - medicine , lung cancer , oncology , docetaxel , atezolizumab , chemotherapy , cancer , hazard ratio , clinical trial , immunotherapy , nivolumab , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom